NMAD — NOMAD Power Solutions Share News
0.000.00%
U.S. STOCKS ON THE MOVE-SpaceX, Tesla, Woodside Energy Group
U.S. STOCKS ON THE MOVE-SpaceX, SharonAI, Medline
U.S. STOCKS ON THE MOVE-SpaceX, SharonAI, Medline
LIXTE to buy battery firm NOMAD, shifts away from cancer drugs; shares rise
NASDAQ RESUMED AT 09:52 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
Brief: Lixte Biotechnology Holdings Expands Collaboration With University Of Texas MD Anderson Cancer Center & GSK For Lb-100
Brief: Lixte Biotechnology Raises $4.3M in Market‑Priced Registered Direct Offering
U.S. STOCKS ON THE MOVE-Applied Materials, CDW, Dell
U.S. STOCKS ON THE MOVE-Applied Materials, CDW, Kohl's
U.S. STOCKS ON THE MOVE-Coinbase, Best Buy, Abercrombie & Fitch
Lixte rises after buying UK firm to enter proton therapy cancer care
Brief: Lixte Biotechnology Holdings Inc - Peter Stazzone Has Been Named Chief Financial Officer
Brief: Lixte Biotech Announces $5 Million Private Placement Priced at Market
Brief: Lixte Biotechnology terminates sales agreement with Wallachbeth Capital
Brief: Lixte Biotechnology Holdings' Eric Forman Resigns As VP And COO Of Lixte Biotech Effective As Of Dec 31
Brief: First Patient Dosed With Lixte’S Lb-100 In New Clinical Trial To Treat Colorectal Cancer
Brief: Lixte Biotechnology Got Into Clinical Trial Agreement With Netherlands Cancer Institute
Brief: Lixte Biotechnology Holdings Provides Update On Recent Activities